An Analysis of the Biological Disease-modifying Antirheumatic Drug-free Condition of Adalimumab-treated Rheumatoid Arthritis Patients

OBJECTIVES: The present study was performed with the aim of analyzing the biological disease-modifying antirheumatic drug (bDMARD)-free (Bio-free) condition of adalimumab (ADA)-treated rheumatoid arthritis (RA) patients in a real-world setting. METHODS: ADA was used in the treatment of 130 (male, n=...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Satoshi, Kobayashi, Daisuke, Hasegawa, Eriko, Takai, Chinatsu, Nemoto, Tetsuya, Lee, Hyunho, Abe, Asami, Otani, Hiroshi, Ishikawa, Hajime, Murasawa, Akira, Narita, Ichiei, Nakazono, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421140/
https://www.ncbi.nlm.nih.gov/pubmed/30210123
http://dx.doi.org/10.2169/internalmedicine.1332-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421140/
https://www.ncbi.nlm.nih.gov/pubmed/30210123
http://dx.doi.org/10.2169/internalmedicine.1332-18

Ejemplares similares